retatrutide nonalcoholic fatty liver disease nash trial in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment Efficacy and safety of subcutaneous

J Obes Metab Syndr 32:2545

Phase 2: keto transition (weeks 7-10) This is when you drop carbohydrates under 20 to 30 grams of net carbs daily and enter nutritional ketosis

A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes

Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness